Document

We consent to the incorporation by reference in Registration Statement No. 333-262711 on Form S-3 and Registration Statement Nos. 333-271710, 333-262713, and 333-252119 on Form S-8 of our report dated March 7, 2024, relating to the financial statements of Foghorn Therapeutics Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2023.